Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6539502

O=C(Nc1ccc(Br)cc1)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 18/20 0.80
ADRB1 P08588 16/20 0.80
ADRB2 P07550 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6539346 0.92 ADRB3 (0.76) ADRB3ADRB1ADRB2KDM4EMEN1
Trifluoroacetic Acid SCHEMBL6539537 0.92 ADRB3 (0.81) ADRB3ADRB1ADRB2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6538892 0.90 ADRB3 (0.79) ADRB3ADRB1ADRB2MAPT
SCHEMBL6538626 0.89 ADRB3 (1.00) ADRB3ADRB1ADRB2ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6538830 0.88 ADRB3 (0.76) ADRB3ADRB1ADRB2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6539378 0.88 ADRB3 (0.76) ADRB3ADRB1KDM4ESMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6538594 0.88 ADRB3 (0.98) ADRB3ADRB1ADRB2MAPT
Trifluoroacetic Acid SCHEMBL6539484 0.88 ADRB3 (0.91) ADRB3ADRB1ADRB2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6539498 0.88 ADRB3 (0.75) ADRB3ADRB1ADRB2ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6538873 0.88 ADRB3 (0.75) ADRB3ADRB1ADRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed